Purgo Pouch
Fracture-Related Infections (FRI)
PreclinicalActive
Key Facts
About Purgo Scientific
Purgo Scientific is a private, preclinical-stage biotech company based in San Diego, founded in 2018. The company is developing the Purgo Pouch, a combination product device designed for localized, sustained antibiotic delivery to treat orthopedic biofilm infections, with an initial target indication of fracture-related infections. With clinical testing planned for 2027 and a foundation of preclinical data from over 140 sheep, the company is addressing a significant unmet need in surgical site infections, which cost the U.S. healthcare system $10 billion annually. Purgo Scientific is positioned in the high-stakes medical device and localized therapeutic delivery market within orthopedics.
View full company profile